Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Pancreatic Cancer

NCT03239184 is registered in ClinicalTrials.gov with Fuda Cancer Hospital, Guangzhou as lead sponsor.

NCT NCT03239184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Pancreatic Cancer
Lead sponsor
Fuda Cancer Hospital, Guangzhou
Phase
Phase 2/3
Overall status
Completed
Start date
September 1, 2017
Completion date
September 1, 2018
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable pancreatic cancer